...Midori Ishiyama; Masayuki Shiseki; Kentaro Yoshinaga; Michiko Ryuzaki; Yuki Izuka; Aya Watanabe; Norina Tanaka; Akihito Shinohara; Shotaro Hagiwara; Junji Tanaka To evaluate the long-term efficacy of high-dose dexamethasone (HD-DXM) treatment for immune thrombocytopenia (ITP), we retrospectively...

...Kenshi Suzuki; Kazutaka Sunami; Morio Matsumoto; Akio Maki; Fumika Shimada; Kazuyuki Suzuki; Kazuyuki Shimizu Introduction: Panobinostat, bortezomib, and dexamethasone combination therapy demonstrated progression-free survival (PFS) benefit over bortezomib and dexamethasone alone in the PANORAMA-1...

... approaches would be of value globally. Patients and Methods: All consecutive MM patients diagnosed in the Centro de Hematología y Medicina Interna de Puebla after 1993 were included in this study. Patients were given oral thalidomide (100 mg/day), oral dexamethasone (36–40 mg/week), and aspirin 100 mg/day...

...; Junichi Mukae; Koh Yamamoto; Ikuyo Tsutsumi; Takuya Komeno; Chikashi Yoshida; Masahide Yamamoto; Hiroshi Kojima; on behalf of the Ochanomizu Hematology Study Group We assessed the efficacy and safety of weekly cyclophosphamide-bortezomib-dexamethasone (CBD) induction prior to autologous stem cell...

...Yang Chen; Yanyan Xie; Min Ruan; Jinning Shi Objective: The aim of this work was to investigate the influence of T lymphocyte subsets and platelet-specific autoantibodies on immune thrombocytopenia (ITP) with dexamethasone therapy. Methods: The samples were obtained from patients before therapy. T...

... performed a prospective, randomized, multicenter trial comparing daily prednisone (1-2 mg/kg/day for 2-4 weeks with subsequent dose reduction) with six 3-week cycles of pulsed dexamethasone (0.6 mg/kg/day, days 1-4). The primary endpoint was remission duration. Of 26 patients enrolled, 22 were evaluable...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Bortezomib Dexamethasone Multiple myeloma A total of 20 patients, including 6 over the age of 80 years, were enrolled in this study (table 1 ). For some...

...H.G. Rainer; K. Moser; J. Schwarzmeier Dexamethasone hemisulphate (Dexa-Scheroson®) concentrations of 100 μ /ml culture medium produces a marked inhibition of the incorporation of 14 C-adenine into the trichloroacetic acid precipitate and nucleic acids of granulocytes. Exact analysis...

...Soad Al-Bahar; Ramesh Pandita; A.V. Hoffbran The complication of ‘retinoic acid syndrome’ occurs in 25-30% of patients with acute promyelocytic leukemia (APL) treated with all- trans retinoic acid (ATRA). Early dexamethasone therapy has reduced mortality from this complication. No long-term sequel...

.... Published data on the use of bortezomib in patients with myeloma and renal failure are few. We report our experience with bortezomib and dexamethasone in 3 previously untreated and 1 relapsed patient with MM and renal failure. All patients achieved rapid improvement in their renal function as measured...